Profil
Klaus P.
J.
Theobald is the founder of SciaDerm, Inc. Formerly, Chief Medical Officer & Senior Vice President at CollaGenex Pharmaceuticals, Inc. from 2004 to 2008.
Chief Research & Development Officer at Anterios, Inc. from 2009 to 2016.
Education includes a doctorate from The Johannes Gutenberg University of Mainz.
Anciens postes connus de Klaus P. J. Theobald
| Sociétés | Poste | Fin |
|---|---|---|
Anterios, Inc.
Anterios, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops botulinum products for therapeutic and aesthetic applications | Directeur Technique/Scientifique/R&D | 01/01/2016 |
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets medical therapies to the dental & dermatology market | Directeur Technique/Scientifique/R&D | 10/04/2008 |
SciaDerm, Inc.
SciaDerm, Inc. Pharmaceuticals: MajorHealth Technology Develops novel treatment drugs for treating psoriasis | Fondateur | - |
Formation de Klaus P. J. Theobald
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets medical therapies to the dental & dermatology market | Health Technology |
Anterios, Inc.
Anterios, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops botulinum products for therapeutic and aesthetic applications | Health Technology |
The Johannes Gutenberg University of Mainz
The Johannes Gutenberg University of Mainz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SciaDerm, Inc.
SciaDerm, Inc. Pharmaceuticals: MajorHealth Technology Develops novel treatment drugs for treating psoriasis | Health Technology |
















